ZIVO Bioscience appoints Laith Yaldoo to board, expands to 5 members

Zivo Bioscience, Inc.

Board increased from 4 to 5 members; Laith Yaldoo appointed effective July 11, 2024.
Yaldoo is managing member of HEP Investments LLC; background in biotech, healthcare, and card processing.
He will stand for election as a Class I director at the 2026 annual meeting.
No family relationships or related party transactions with current officers/directors.
Yaldoo will participate in the Company’s standard outside director compensation program.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Laith Yaldoo

Director

ZIVO · Zivo Bioscience, Inc.

Effective: 2024-07-11
Filed: July 17, 2024, 7:59 PM ET

On July 11, 2024, the Board of Directors of ZIVO Bioscience Inc., (the “Company”) increased its size from four (4) to five (5) members and appointed Laith Yaldoo to fill the vacancy.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Laith Yaldoo was appointed as Director at Zivo Bioscience, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 11, 2024, the Board of Directors of ZIVO Bioscience Inc., (the “Company”) increased its size from four (4) to five (5) members and appointed Laith Yaldoo to fill the vacancy.

View on SEC.gov

Zivo Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-24-009069

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.